Long-Acting Basal Insulins for Patients with Diabetes: Distinguishing Formulations for Individualized Care is organized by Med Learning Group.
Dates:
Release Date: August 16, 2019
Expiration Date: August 16, 2020
Accreditation:
Credit Designation Statement:
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Nursing Credit Information:
Purpose: This program would be beneficial for nurses who manage and treat patients with diabetes.
Credits: 1.0 ANCC Contact Hours.
Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.
Description:
This online activity is focused on the team involved in healthcare practitioners who manage and treat patients with diabetes.
Objectives:
After completing the CME activity, learners should be better able to:
• Assess current diabetes guidelines to best implement evidence-based strategies in diabetes
• Review and distinguish current long-acting formulations of insulin therapy and incorporate these agents into a comprehensive treatment plan for patients with T2DM
• Identify barriers to treatment intensification and patient/provider communication for patients with T2DM
Additional details will be posted as soon as information is available.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved